1221257-85-7

Basic information

• Product Name: tert-butyl-5-((4'-formylbiphenyl-4-yl)ethynyl)-2,2-dimethyl-1,3-dioxan-5-ylcarbamate
• Synonyms: tert-butyl-5-((4'-formylbiphenyl-4-yl)ethynyl)-2,2-dimethyl-1,3-dioxan-5-ylcarbamate
• CAS NO: 1221257-85-7
• Molecular Weight: 435.52
• Mol File: 1221257-85-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl-5-((4'-formylbiphenyl-4-yl)ethynyl)-2,2-dimethyl-1,3-dioxan-5-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl-5-((4'-formylbiphenyl-4-yl)ethynyl)-2,2-dimethyl-1,3-dioxan-5-ylcarbamate(1221257-85-7)
• EPA Substance Registry System: tert-butyl-5-((4'-formylbiphenyl-4-yl)ethynyl)-2,2-dimethyl-1,3-dioxan-5-ylcarbamate(1221257-85-7)

Safety Data

• Hazardous Substances Data: 1221257-85-7(Hazardous Substances Data)

Upstream product

• 1221257-84-6 tert-butyl-5-((4-bromophenyl)ethynyl)-2,2-dimethyl-1,3-dioxan-5-ylcarbamate 
• 87199-17-5 4-formylphenylboronic acid, 

Downstream Products

• 1221257-86-8 (E)-tert-butyl 4-(4'-(((4-fluorophenyl)(isopropyl)amino)-methyl)biphenyl-4-yl)-1-hydroxy-2-(hydroxymethyl)but-3-en-2-ylcarbamate 

Relevant articles and documents

S1P RECEPTORS MODULATORS

The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.